1 line
2.5 KiB
JSON
1 line
2.5 KiB
JSON
{"Anaplastic thyroid cancer": 1006.3657503455536, "BRAF V600E mutation positive": 1004.5702561249988, "Blood creatine phosphokinase increased": 5.361261175640397, "Blood lactate dehydrogenase increased": 6.416465175399551, "Blood test abnormal": 9.799284165527297, "C-reactive protein increased": 2.9745741184208128, "Cognitive disorder": 2.78332873890958, "Colitis": 2.4084367606706825, "Dermatitis acneiform": 14.005125160685402, "Disease progression": 3.3771378019265934, "Disease recurrence": 2.3186438956629987, "Drug reaction with eosinophilia and systemic symptoms": 3.60401680676962, "Drug resistance": 8.563251101083688, "Dysphagia": 2.5750605699166345, "Ejection fraction decreased": 28.59351053125258, "Erythema nodosum": 15.347927069937317, "Fear": 4.666537695235013, "Haemophagocytic lymphohistiocytosis": 14.5978623926523, "Hepatitis": 2.43402874286642, "Hepatotoxicity": 2.916078764798514, "Hyperpyrexia": 4.713689506436015, "Hyperthyroidism": 2.131478155385784, "Intentional product use issue": 2.141262215847849, "Liver function test increased": 2.319048612076317, "Lung adenocarcinoma": 25.76589602633331, "Malignant melanoma": 62.77887682052799, "Malignant melanoma stage IV": 110.14107887544486, "Malignant neoplasm progression": 33.366863067596874, "Melanoma recurrent": 101.38713681701633, "Metastases to bone": 10.48483944623639, "Metastases to central nervous system": 74.25310461855811, "Metastases to liver": 13.449048807140931, "Metastases to lung": 26.540211495558733, "Metastases to lymph nodes": 30.70553947850328, "Metastases to meninges": 59.98765145654069, "Metastases to skin": 77.26958700981854, "Metastasis": 11.510920545905874, "Metastatic malignant melanoma": 398.4923391902726, "Mucosal inflammation": 6.212920658691106, "Neoplasm": 9.161247639507623, "Neoplasm progression": 2.573619239728883, "Neutropenia": 3.155029599247391, "Non-small cell lung cancer": 13.876856684339211, "Oesophagitis": 10.19261524565018, "Panniculitis": 33.217689177885575, "Pemphigoid": 4.396866657824431, "Peripheral motor neuropathy": 45.268081504696575, "Peripheral sensory neuropathy": 10.448255366274385, "Pneumonitis": 8.993253828545377, "Polyneuropathy": 4.975738969265043, "Product use in unapproved indication": 5.758567984652719, "Pulmonary mass": 6.528449299665128, "Pyrexia": 2.485805349985104, "Rhabdomyolysis": 2.4133314712281444, "Sarcoidosis": 11.07554627931574, "Skin toxicity": 23.81092598567872, "Therapeutic response decreased": 6.037042566921579, "Therapy partial responder": 40.26413926134357, "Uveitis": 35.17084728831189} |